<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://dealbreaker.com/.rss/full/</title><link>https://dealbreaker.com/.rss/full/</link><description>Individual feed output.</description><lastBuildDate>Thu, 01 Jan 2026 06:05:56 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>European Defense Firm KNDS Targets 2026 For Dual Stock Exchange Listing</title><link>https://dealbreaker.com/2025/12/european-defense-firm-knds-targets-2026-for-dual-stock-exchange-listing</link><image_url>https://dealbreaker.com/.image/c_fit%2Ch_800%2Cw_1200/MjIwMjQxMjMwNjg3MTE4NDA2/knds.jpg</image_url><description>The firm, a joint venture between Germany's Krauss-Maffei Wegmann and France's Nexter, amassed an order intake of €11.2 billion ($13.1 billion) in 202...</description><pubDate>Thu, 18 Dec 2025 18:00:00 GMT</pubDate></item><item><title>Anatomy Of A Modern Merger: Finding Long-Term Success</title><link>https://dealbreaker.com/2025/12/anatomy-of-a-modern-merger-finding-long-term-success</link><image_url>https://dealbreaker.com/.image/c_fit%2Ch_800%2Cw_1200/MjA0MDQ3NjQyMjIzNzE1OTAw/office-building.jpg</image_url><description>Our road map for GCs takes you from due diligence to integration.</description><pubDate>Wed, 17 Dec 2025 18:00:00 GMT</pubDate></item><item><title>AI Summit 2025: 10 Takeaways And Some Unanswered Questions</title><link>https://dealbreaker.com/2025/12/ai-summit-2025-10-takeaways-and-some-unanswered-questions</link><image_url>https://dealbreaker.com/.image/c_fit%2Ch_800%2Cw_1200/MTYxMjc3Njc4MjExODM1ODY4/robots.png</image_url><description>Right now, our relationship with AI is like one where hard issues are always put off. That never ends well.</description><pubDate>Wed, 17 Dec 2025 17:00:00 GMT</pubDate></item><item><title>Mass General Brigham Spins Out Generative AI Startup</title><link>https://dealbreaker.com/2025/12/mass-general-brigham-spins-out-generative-ai-startup-</link><image_url>https://dealbreaker.com/.image/c_fit%2Ch_800%2Cw_1200/MjIwMjMyMTM5ODUxOTY2MzE3/mass-general-brigham.jpg</image_url><description>The tool’s primary application is to accelerate and improve the accuracy of patient screening for clinical trials.</description><pubDate>Tue, 16 Dec 2025 20:00:00 GMT</pubDate></item><item><title>Sobi Grows Its Gout Drug Prospects With $950M Acquisition of Startup Arthrosi Therapeutics</title><link>https://dealbreaker.com/2025/12/sobi-grows-its-gout-drug-prospects-with-950m-acquisition-of-startup-arthrosi-therapeutics</link><image_url>https://dealbreaker.com/.image/c_fit%2Ch_800%2Cw_1200/MjE3MzM1MTUwODU2MzgxNTc4/pills.jpg</image_url><description>Arthrosi Therapeutics’ pozdeutinurad is in Phase 3 testing as a treatment for uncontrolled gout.</description><pubDate>Tue, 16 Dec 2025 19:00:00 GMT</pubDate></item></channel></rss>